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Stromal SLIT2 impacts on pancreatic cancer-associated
neural remodeling
V Secq1,2, J Leca1, C Bressy1, F Guillaumond1, P Skrobuk1, J Nigri1, S Lac1, M-N Lavaut1,2, T-t Bui1, AK Thakur1, N Callizot3,
R Steinschneider3, P Berthezene1, N Dusetti1, M Ouaissi4, V Moutardier1, E Calvo5, C Bousquet6, S Garcia1,2, G Bidaut1,
S Vasseur1, JL Iovanna1 and R Tomasini*,1
Pancreatic ductal adenocarcinoma (PDA) is a critical health issue in the field of cancer, with few therapeutic options. Evidence
supports an implication of the intratumoral microenvironment (stroma) on PDA progression. However, its contribution to the role of
neuroplastic changes within the pathophysiology and clinical course of PDA, through tumor recurrence and neuropathic pain,
remains unknown, neglecting a putative, therapeutic window. Here, we report that the intratumoral microenvironment is a mediator
of PDA-associated neural remodeling (PANR), and we highlight factors such as ‘SLIT2’ (an axon guidance molecule), which is
expressed by cancer-associated fibroblasts (CAFs), that impact on neuroplastic changes in human PDA. We showed that
‘CAF-secreted SLIT2’ increases neurite outgrowth from dorsal root ganglia neurons as well as from Schwann cell migration/
proliferation by modulating N-cadherin/β-catenin signaling. Importantly, SLIT2/ROBO signaling inhibition disrupts this stromal/
neural connection. Finally, we revealed that SLIT2 expression and CAFs are correlated with neural remodeling within human and
mouse PDA. All together, our data demonstrate the implication of CAFs, through the secretion of axon guidance molecule,
in PANR. Furthermore, it provides rationale to investigate the disruption of the stromal/neural compartment connection with
SLIT2/ROBO inhibitors for the treatment of pancreatic cancer recurrence and pain.
Cell Death and Disease (2015) 6, e1592; doi:10.1038/cddis.2014.557; published online 15 January 2015
Even after significant efforts from the scientific community in
the past decade, pancreatic ductal adenocarcinoma (PDA)
remains one of the most lethal cancers with worrying
predictions.1 Median survival stagnates around 5 months,
together with a 5-year survival at 5%. For 5–20% of patients
treated surgically, the 5-year survival reaches 20%, with a
median survival of 16 months. Metastasis onset and high
prevalence of local tumor recurrence after potential curative
resection influence patient’s survival. A recent study revealed
that the overall survival of patients with tumor recurrence was
9.3, versus 26.3 months for patients without early relapse.2,3
Although several causes are attributed to local recurrence,
reports highlight intrapancreatic nerve invasion as a predictor
for recurrence4 by playing the role of a specific niche for
scattered tumoral cells. In light of such epidemiologic data,
there is a crucial need to develop optimal therapeutic
strategies, taking into account the tumoral cellular composi-
tion, over the next decade.5
Tumors are complex tissues in whichmutant cancer cells and
subverted normal cells coexist and interact to form an intricate
network. This is even more accurate for PDA, in which tumor
stroma (intratumoral microenvironment), representing 90% of
the tumor mass, is considered as an emerging hallmark.6 It is
composed of the extracellular matrix, mesenchymal cells
(cancer-associated fibroblasts, CAFs), blood and lymphatic
vessels, nerve fibers and inflammatory cells. This stromal
compartment is particularly active in tumor development7,8 and
clinical outcome.9 However, although genetic changes in tumor
epithelial cells have been deeply investigated in the past
decades,10 investigation into the role of stromal cells has largely
lagged behind and is nowadays of major interest.
Beyond the presence of an important stromal compartment,
another characteristic of PDA is the presence of a modified
innervation in nearly all patients. This includes increased neural
density, hypertrophy and pancreatic neuritis, as well as intra-
and extrapancreatic perineural invasion (PNI) by cancer
cells.11,12 This neural remodeling or PDA-associated neural
remodeling (PANR) is clinically correlated with neuropathic
pain12,13 and locoregional spread14 and is a marker of poor
prognosis.15,16 As noted above, several studies reported neural
remodeling as one reason for local tumor recurrence after
curative resection, with residual tumor cells present in the
remnant pancreas nerves.17Moreover, PNIwas recently shown
as an independent prognostic factor18 and even as the more
accurate predictor for recurrence.19 Beyond a clear clinical
significance, PANR pathogenesis and associated molecular
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mechanisms are still poorly understood.20–23 Improvement of
our knowledge on molecular pathways underlying PANR may
lead to better prognostic indicators as well as to innovative
therapeutic strategies targeting local recurrence and locoregio-
nal spread, as well as cancer-associated pain.
Here, we realized microarray transcriptomic analysis of
stromal versus tumoral cell compartments from several PDA
patients, and highlighted stromal neurogenic factors potentially
impacting on PANR. Among them, we further examined the
specific involvement of axon guidance molecules SLIT2 within
in vitro and in vivomodels. Finally, our results reveal a key role of
intratumoral microenvironment on PANR and suggest that
inhibiting tumor–stroma interactions could be a promising
therapeutic strategy to hold down processes involved in
disease recurrence and associated neuropathic pain.
Results
Determination of stromal and tumoral cell compartment
transcriptomic signatures and characterization of an
enriched ‘axon guidance’ family. Clinical hallmarks of
PDA are the abundant stromal reaction and the presence of
PANR (Supplementary Figure 1A), which have been widely
separately documented.11 However, the connection between
these two processes is limited to a unique study revealing
that neuronal plasticity can be induced by extracts from
PDA’s stromal compartment.24 To analyze the impact of the
intratumoral microenvironment on PANR, we decided to
decipher the transcriptomic profile of the stromal cell
compartment within the human PDA tissue. We used laser
capture microdissection on human PDA samples to separate
epithelial cells from stromal ones and analyzed their relative
gene expression profiles using the Affymetrix U133 gene chip
set followed by significance analysis of microarray (SAM)
analyses (Supplementary Figures 1B and C; GEO repository
GSE50570). We then realized a GO global enrichment
analysis using only genes overexpressed in the stromal
compartment with a significant P-value (1001 genes) and
highlighted an ‘axon guidance’ family including 48 genes with
an enrichment P-value of 5.42E− 8 (Supplementary Figure
1D). This family represents a total of 4.8% of all genes
overexpressed in the stromal compartment within PDA.
Those data indicate that the stromal compartment within
PDA specifically produces molecules that could impact on
axon guidance and nerve cell abilities, and thus on PANR.
Among the key factors from the intratumoral microenvir-
onment, SLIT2, an axon guidance molecule, is mainly
expressed by CAFs. As PANR is characterized by an
increased nerve density, this ‘axon guidance’ family seems
conceptually relevant. Indeed, such a process could be
involved in the attraction and growth of new and/or existing
nerve fibers within PDA tumor. Among those 48 genes present
in the ‘axon guidance’ family (Supplementary Figure 1D), we
observed two members (ROBO1 and SLIT2) of a well-known
axon guidance axis, the SLIT/ROBO signaling pathway,
recently associated with pancreatic cancer genome aberration
and patient survival.10 Moreover, SLIT2 is one of the most
overexpressed genes among ‘axon guidance’ genes, with a
13.9-fold increased expression (Supplementary Figure 1D).
We first analyzed in vivo the expression pattern of SLIT2 and
showed by immunohistochemistry (IHC) and immunofluores-
cence (IF) (Figure 1a) that it was mainly expressed in the
stromal compartment and more precisely within CAFs, as
shown by coimmunostaining with α-smooth muscle actin
(αSMA), a PDA CAF marker. SLIT2 expression in CAFs was
also shown using primary CAFs extracted from seven different
patients, and a higher expression than in epithelial tumoral
cells was confirmed with a fold increase range of 4.9e4–9.9e5
depending on primary CAF culture (Po0.001; Figure 1b).
More importantly, we show that SLIT2 level is increased in
PDA compared with healthy pancreas in human (Figure 1c) as
well as in an endogenous mouse model: the pdx1-cre/
KrasG12D/Ink4Af/f mice25 (Figure 1d). In this mouse model,
Slit2 was also localized in the stromal compartment by IHC
(Figure 1e) and more specifically in CAFs (Figure 1f).
Altogether, our in vivo and in vitro data suggest that the
stromal compartment and, more precisely, CAFs express the
axon guidance molecule, SLIT2, which could impact on PANR.
In vitro modeling of intratumoral microenvironment cell
interactions. To analyze the impact of the stromal compart-
ment on PANR in vitro, we designed an in vitro model
constituted of human primary fibroblasts and murine macro-
phages cultivated on collagen matrix (Figure 2a). We first
checked the relevance of this model and observed that primary
fibroblasts cocultivated with macrophages show increased
expression of αSMA, a well-known CAF marker within PDA
(Figure 2b). This suggests that, in coculture condition with
macrophages, autocrine/paracrine components are able to
switch on the activation process of primary fibroblasts by
turning them into CAF-like cells mimicking the intratumoral
microenvironment. Interestingly, in those culture conditions,
the protein level of SLIT2 is increased 5.1±0.3-fold in
fibroblasts cultivated alone and in fibroblasts cocultured with
macrophages (Po0.01; Figure 2c). To validate such a concept
with our own data, we analyzed the expression level of several
members of the ‘axon guidance’ family highlighted by gene
enrichment, and observed a CAF-like expression pattern, as
all members tested were overexpressed in fibroblasts cocul-
tured with macrophages, compared either with fibroblasts
alone or with epithelial tumoral cells (Figure 2d), whereas none
of them were increased in macrophages cocultured with
fibroblasts (Supplementary Figure 2). These data suggest that
our in vitro model can mimic the PDA intratumoral micro-
environment and thus could be used as an efficient in vitro
model to decipher the modulation and impact of the
intratumoral microenvironment on PANR.
Media from our in vitro model induce changes in neuron
and Schwann cell behaviors. So far, a unique study has
revealed that pancreatic tumor extracts (mix of proteins from
every cell type composing PDA) can induce neuronal
plasticity through the increase of neurite density and neuronal
branch length.24 To definitively confirm the strength of our
in vitro model and also emphasize our leading hypothesis on
the role of the stromal compartment on PANR, we first
submitted dorsal root ganglion (DRG) neurons to our stromal
conditioned media (which showed the overexpression of 9/15
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genes from the ‘neurogenic factor family’) versus control
conditioned media. Interestingly, we observed that stromal
conditioned media (FcoM) significantly increase the total
number of neurons (relative fold change compared with
control: 1.6± 0.17, Po0.05) and, more specifically, large
neurons (relative fold change compared with control of
1.5± 0.21, Po0.05; Figure 3a), and favor neuronal networks
(Supplementary Figure 3A) and branching pattern (relative
fold change compared with control of 1.4±0.15 for two
extensions, Po0.05, and 2.3±0.3 for three or more
extensions, Po0.05; Figure 3b), which represent crucial
parameters for nerve formation, extension and regeneration
after an injury or within physiopathological circumstances.26
These data, which validate previous observations,24 further
highlight the direct implication of the intratumoral micro-
environment in PANR.
However, while neuronal modulation is important for neural
remodeling, processes associated with Schwann cell behavior
(main nerve fiber cell components tightly associated with
neurons) are also involved in fiber attraction and sprouting.27
Interestingly, we showed that stromal conditioned media
(FcoM) significantly enhance Schwann cell proliferation
(5.75± 0.4 versus 3.6±0.3 for control condition) (cell counting
fold change; Po0.01 (Figure 3c) and mitochondrial activity;
Po0.05 (Supplementary Figure 3B)) as well as Schwann cell
migration, with 14.3± 2.7 for FcoM media versus 5±2.5 for
F+M media and 1± 0.9 for SNF media (Po0.05 and Po0.01;
Figure 3d). All together, our data confirmed that the
intratumoral microenvironment is able to modify several
neurons and Schwann cell abilities that can be related to
processes involved in PANR.
Figure 1 SLIT2 expression pattern in CAFs of the stromal compartment within human (h) and mouse PDA. (a) IHC and IF images of human PDA stained for SLIT2 (upper
left), SLIT2 (red) and cytokeratin 19 (CK19) (green) in the upper right and SLIT2 (red) and αSMA (green) in the lower left. Fluorescence intensity quantification (of IF staining) was
carried out on four human PDA (magnification: × 20) (**Po0.01) using Image J software. (b) SLIT2 mRNA quantification by quantitative real-time PCR (QRT-PCR) in CAFs
extracted from seven different human PDA versus human pancreatic tumoral cell lines, Miapaca2 (Mia) as reference (value at 0.00001e5), Panc1 (Pc1) and Capan-2 (Cp2)
(***Po0.001). (b, inset) IF representative images of CAFs stained for SLIT2 (green) and αSMA (red) (magnification: × 20). (c) Western blot of SLIT2 expression in protein
extracts from human PDA or healthy human pancreas (demonstrating the increased expression of SLIT2 in PDA extracts). Actin was used as a loading control. (d) SLIT2 mRNA
quantification by QRT-PCR in the pancreas of 8-week-old healthy mice (KrasG12D/Ink4Af/f) and PDA-bearing mice (pdx1-cre/KrasG12D/Ink4Af/f) (**Po0.01). (e) SLIT2 expression
and HE counterstaining of pancreas from 8-week-old healthy mice and PDA-bearing mice (upper images) and SLIT2 staining (lower images). *, Epithelial/ductal tumoral cells/
structures; arrows, stromal/fibroblast compartment. (f) Representative IF images of CAFs labeled with αSMA (red) and SLIT2 (green) in mouse PDA (magnification: × 20; scale
bar: 100 μm)
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The SLIT2/ROBO pathway impacts directly on nerve cell
behaviors linked to PANR. To determine the real impact
of SLIT2 and consequent signaling on PANR, we took
advantage of our in vitro model. Following our hypothesis
that CAFs produce SLIT2, which then impacts on PANR, we
first depleted secreted SLIT2 in the conditioned medium.
As suspected, we observed that the increase in Schwann cell
migration induced by fibroblasts cocultured with macro-
phages in the conditioned medium (14.2 versus 4.2 for FcoM
media, Po0.01) is lost after SLIT2 depletion (14.2–4.3,
Figure 2 In vitro model and axon guidance molecule expression in vitro. (a) Graphical representation of the technical procedure used to mimic in vitro the PDA intratumoral
compartment and to produce conditioned media (Cd media). (b) IF images of αSMA staining on human fibroblasts alone (F) or cocultured with macrophages (FcoM), human PDA
(PDA) or CAF from human PDA (magnification: × 20 and × 40 for in vivo and in vitro images, respectively). (c) Representative images of fibroblasts (F) or fibroblasts cocultured
with macrophages (FcoM) labeled for SLIT2 (green). SLIT2 quantification from IF staining on fibroblasts (F, used as normalizer) or fibroblasts cocultured with macrophages
(FcoM) (n= 3; **Po0.01). (d) Human mRNA level of some genes composing the ‘axon guidance’ family was analyzed by quantitative real-time PCR (QRT-PCR) in human
pancreatic tumoral cell lines (Miapaca2 used as normalizer, except for ROBO1, which are not expressed in Miapaca2, and Panc1), human fibroblasts (F) and human fibroblasts
cocultured with mouse macrophages (FcoM). Light green, Po0.05 versus Panc1; dark green, Po0.05 versus F (n= 3). Md, conditioned media from: SNF, sNF 96.2;
F, fibroblasts; M, macrophages; F+M, mixed Md from separated cultures of fibroblasts and macrophages; FcoM, cocultures of fibroblasts and macrophages
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Po0.01; Figure 4a). This result is specifically due to SLIT2
depletion, as adding a blocking peptide to the medium reverts
the phenotype (4.3–11.9, Po0.01; Figure 4a). This suggests
that SLIT2 within the FcoM medium seems to be responsible
for the enhanced Schwann cell migration. To confirm this
hypothesis, we silenced SLIT2 mRNA in fibroblasts using
siRNA (Supplementary Figure 4A). We showed that the
conditioned medium from SLIT2-deficient fibroblasts cocul-
tured with macrophages no longer increases Schwann cell
migration (15.6-fold for FcoM Si-Ctr to 5.9-fold for FcoM Si-
Slit2, Po0.01; Figure 4b). In this context, we also show that
SLIT2 recombinant protein enhances Schwann cell migration
by 1.5±0.1-fold (Po0.01; Figure 4c). These data confirm
that SLIT2, produced by fibroblasts when cocultured/
activated with macrophages, is able to improve Schwann
cell migration abilities.
The SLIT2 ligand is recognized and binds to members of the
ROBO receptor family.28 According to our model, Schwann
cells used in the above experiments should express ROBO
receptors, and its inhibition by siRNA should impair SLIT2
effects onmigration. As shown in Supplementary Figures 4B–D,
ROBO receptors are expressed in Schwann cells in vitro as
well as in nerve fibers within human PDA samples. After
validation of our siRNA targeting ROBO receptors in Schwann
cells (Supplementary Figures 4C and D), we could show that
ROBO1 and ROBO2 depletion in Schwann cells markedly
impaired the induction of Schwann cell migration owing to the
FcoM conditionedmedium (Po0.001 for Robo1 depletion and
Po0.05/0.01 for Robo2 depletion; Figure 4d). These data
strengthen our hypothesis on the impact of the intratumoral
microenvironment on PANR through the direct implication
of SLIT2.
SLIT2 modulates N-cadherin/β-catenin signaling to influ-
ence Schwann cells' migratory ability. The highly con-
served SLIT family, and their receptors ROBO, are well
known to participate in central nervous system patterning as
well as in sensory axon elongation and branching.28 Binding
of SLIT2 to Robo inhibits N-cadherin-mediated adhesion by
inducing the separation of β-catenin from the cytoplasmic
part of N-cadherin leading to its direct nuclear localization
where it alters the transcription of migration/proliferation
targets.29,30 Thus, we investigated whether SLIT2-mediated
impact on Schwann cell abilities could be due to an activation
of the N-cadherin/β-catenin pathway in these cells. We first
examined N-cadherin/β-catenin binding and observed that
FcoM medium decreases their co-immunoprecipitation after
30min (1 for F+M media versus 0.2±0.1 for FcoM media,
Po0.01; Figure 5a). We confirmed that this effect was
correlated with the presence of SLIT2 within FcoM condi-
tioned medium using conditioned medium established with
fibroblasts transfected with control (Si-Ctr) or Slit2 (Si-SLIT2)
siRNAs. Indeed, the use of FcoM media from si-Ctr-treated
fibroblasts cocultured with macrophages showed a decrease
in N-cadherin/β-catenin binding (1± 0.2 versus 0.4±0.3,
Po0.05), whereas the use of FcoM media from si-SLIT2-
treated fibroblasts cocultured with macrophages did not
reveal any changes (0.9±0.3 versus 1.3± 0.3, NS;
Figure 5b). We then studied the consequent translocation
of free β-catenin into the nucleus by analyzing nuclear
extracts from SNF cells incubated with various conditioned
media and revealed by western blot (Figure 5c) and by IF
(Supplementary Figure 5) that FcoM media increase the
nuclear β-catenin amount (1 versus 2.2±0.3, Po0.01;
Figure 5c, left panel). This effect was specifically related to
the presence of SLIT2 as FcoM media from si-SLIT2-treated
fibroblasts cocultured with macrophages could not induce
such β-catenin translocation (2.2±0.3 versus 0.9±0.2,
Po0.01; Figure 5c, right panel). Finally, we confirmed that
nuclear β-catenin was transcriptionally active as FcoM
medium is able to significantly increase the expression level
of some of its targets (C-MYC, TCF4 and MMP9) known to be
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Figure 3 Intratumoral microenvironment induces changes in the primary sensory neurons (a and b) and Schwann cell behaviors (c and d). (a) Growth in primary sensory
neurons (Total, large and small neurons) cultured for 5 days in various conditioned media (Md) (N= 3). (b) Branching pattern was measured in 5-day cultured sensory neurons by
counting the number of neuritis/extensions by neurons (N= 3). (c) Human Schwann cell proliferation was measured by cell counting 72 h after incubation with various conditioned
media. (d) Migration assay: human Schwann cells were assessed for migration abilities on Boyden chamber assay for 4 h (n= 3; *Po0.05; **Po0.01). Md, conditioned media
from: SNF, sNF 96.2; F, fibroblasts; M, macrophages; F+M, mixed Md from separated cultures of fibroblasts and macrophages; FcoM, cocultures of fibroblasts and macrophages
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Figure 4 SLIT2/ROBO pathway impacts on neural cells behaviors linked to PANR. (a–d) Migration assay: human Schwann cells were assessed for migration
abilities on Boyden chamber assay for 4 h with (a) various conditioned media±SLIT2 antibody (Slit2-Ab) to deplete SLIT2 from the conditioned media± blocking peptide
(SLIT2-BP) as control. (b) Conditioned media from control (SNF), mixed (F+M) or cocultures (FcoM) using fibroblasts transfected with control or SLIT2 targeting siRNA.
(c) SNF conditioned medium supplemented, or not, with 25 pg of human recombinant SLIT2. (d) Conditioned medium from control (SNF), mixed (F+M) or cocultures (FcoM)
applied on Schwann cells transfected with control or Robo1 (A and B) or Robo2 (A and B) targeting siRNA. (a–d) (n= 3; *Po0.05; **Po0.01; ***Po0.001). Md, conditioned
medium from: SNF, sNF 96.2; F, fibroblasts; M, macrophages; F+M, mixed Md from separated cultures of fibroblasts and macrophages; FcoM, cocultures of fibroblasts and
macrophages
Figure 5 SLIT2 modulates N-cadherin (N-Cadh)/β-catenin (β-cat) signaling to influence Schwann cell migration ability. (a) N-cadherin/ β-catenin binding was analyzed by
co-immunoprecipitation (IP) in SNF cells after incubation with F+M (control) or FcoM media. (n= 3). (b) N-cadherin/β-catenin binding was analyzed by co-immunoprecipitation in
SNF cells after incubation with F+M (control) or FcoM media from fibroblasts transfected with Ctr (Si-Ctr) or SLIT2 (Si-SLIT2) siRNA. (n= 3). (c) Nuclear extracts from SNF cells
incubated with SNF, F+M or FcoM media (with fibroblasts transfected with Si-Ctr or Si-SLIT2 siRNA) were analyzed for β-catenin expression. Lamin A/C was used as a loading
control and β-tubulin was used asa quality control of nuclear extracts. β-Catenin expression was normalized to respective lamin A/C expression (n= 3). (d) mRNA level of three
β-catenin targets (C-MYC, LCF4 and MMP9) analyzed by quantiative real-time PCR (QRT-PCR) in SNF cells after incubation with SNF (used as normalizer), F+M or FcoMmedia
(n= 3; *Po0.05; **Po0.01; ***Po0.001). Md, conditioned media from: SNF, sNF 96.2; F, fibroblasts; M, macrophages; F+M, mixed Md from separated cultures of fibroblasts
and macrophages; FcoM, cocultures of fibroblasts and macrophages
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related to Schwann cell migration (Figure 5d). These results
indicate that FcoM medium, through the presence of SLIT2,
is able to induce the activation of the β-catenin pathway by
having an impact on the proliferative and migratory abilities of
Schwann cells.
SLIT2 expression is correlated with PANR in vivo. To
reinforce the in vivo and in vitro data obtained, we
investigated the correlation between Slit2 and αSMA expres-
sion levels in vivo within PDA from endogenous mouse
models and found a high positive correlation between both
stainings (Figure 6a and Supplementary Figure 6A). This
suggests that Slit2 within PDA is dependent on the presence
of CAFs. To determine whether SLIT2 level could be
correlated with PANR and nerve density, we counted intra-
and peritumoral nerves in PDA from 14 pdx1-cre/KrasG12D/
Ink4Af/f mice (Supplementary Figure 6A). Interestingly, we
found a positive and significant correlation (r=0.954;
Po0.001) between intratumoral nerve and SLIT2 level
(Figure 6b). A positive correlation was also found between
peritumoral as well as total nerve count and SLIT2 level
(Supplementary Figure 6B). We decided to validate these
correlations on human samples using xenograft tumors
generated in nude mice by implanting pieces of freshly
resected human PDA tumors. As described previously, we
also revealed a positive and significant correlation between
nerve count (peri, intra and total) and SLIT2 level (Po0.001;
Figure 6c and Supplementary Figure 6C). Finally, to correlate
these in vivo data with previously shown information of SLIT2
impact on the proliferation rate of Schwann cells, we
analyzed the proliferation rate of Schwann cells in vivo.
We revealed that nerves with Ki67-positive Schwann cells in
mouse PDA tumors with a high level of SLIT2 (αSMA+/
SLIT2+) are significantly increased compared with nerves
present in mouse PDA with a low level of SLIT2 (αSMA− /
SLIT2− ) (Figure 6d). All together, these data confirm that
SLIT2 produced by CAFs within the PDA stromal compart-
ment in vivo is related to nerve fiber density.
Discussion
Over the past 25 years, the vast majority of studies
concentrated on the possible shortcomings of pancreatic
tumoral cells and designed specific drugs/molecules targeting
those cells. However, PDA is important among solid cancers
because of its cellular composition. Data from an accurate
mouse model of PDA revealed that the poor response of
patients to systemic therapies could be due to two major
concomitant morphological characteristics of these tumors:
their deficient vasculature and the presence of a dense
stromal matrix.7,8 Indeed, several recent lines of evidence
have highlighted the impact of massive hypoxic features on
PDA progression through the modulation of tumor metabolism
and metastasis onset,31 and its implication in chemotherapy
resistance owing to deficiencies in blood vessels. So, tumoral
architecture is a key parameter to integrate before to reach
success in curative treatment.
In the past 5 years, several groups have reported that neural
compartment modulation within PDA significantly influences
the patient's survival and life quality.13 Through significant
action on tumor recurrence4,19 or neuropathic-associated
pain,12 the neural compartment evolveswithin the intratumoral
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Figure 6 SLIT2 is positively correlated with PANR in vivo. (a) Correlation between αSMA expression and SLIT2 level in pancreatic tumor samples from eight PDA-bearing
mice. (b) Correlation between Slit2 score and the number of intratumoral nerves (It-tum nerve) in pancreatic tumor samples from 12 PDA-bearing mice. (c) Correlation between
SLIT2 level and number of intratumoral nerves (It-tum nerve) in 15 human PDA xenograft samples. (d) Count of nerves positive for Ki67 staining in Schwann cells, using 10 mouse
PDA samples with high (n= 5) or low (n= 5) SLIT2 level
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microenvironment and interacts with stromal and tumoral
cells. Here, we provide evidence that the intratumoral
microenvironment and, more specifically, CAFs, through
production/secretion of axon guidance impacting molecules,
influence the PANR by modulating various cellular processes
in neurons and Schwann cells (Supplementary Figure 7), as
supported by the following results: (i) the PDA stromal
transcriptomic signature, obtained after microdissection of
human PDA samples, revealed an ‘axon guidance’-enriched
family containing 48 genes, thus 4.8% of total PDA stromal
transcriptiomic signature; (ii) in vitro heterotypic cultures,
designed to mimic the intratumoral microenvironment cell
dialog, confirmed that members of the ‘axon guidance’ family
were mainly expressed in the stromal compartment rather
than in the tumoral epithelial cell compartment and suggested
that CAFs were specifically involved; (iii) conditioned media
from in vitro heterotypic cultures induce phenotypic changes in
DRG neuron behaviors and Schwann cell abilities that could
be associated with the PANR phenotype. Among key factors
from the PDA intratumoral microenvironment, Slit2, an axon
guidance molecule, (iv) is produced by CAFs and (v) impacts
on similar neural cell abilities associated with PANR, through
the modulation of the N-cadherin/β-catenin pathway in
Schwann cells. (vi) Finally, we showed that SLIT2 level could
influence PANR within endogenous mouse models of
pancreatic cancer (pdx1-cre/KrasG12D/Ink4Af/f) and human
PDA xenografts in nude mice, as the SLIT2 level correlated
with increased intratumoral nerve fiber density.
This study reveals for the first time the PDA transcriptional
signature of stromal and tumoral compartments from the same
patient. Interestingly, we observed after bioinformatic analysis
that the stromal signature includes mainly genes encoding for
secreted factors, while the tumoral signature involves mainly
genes related to cell behaviors (proliferation, apoptosis,
traduction, migration, and so on). This is consistent with
ongoing hypothesis and knowledge as the stromal compart-
ment is lowly proliferative and highly secreted, while the
tumoral cell compartment is highly proliferative/migrating and
resistant to apoptosis.7 Describing CAFs as a ‘secretory
machine’ suggests that those cells constitute a key cell
component of PDA, which is able to influence all functional
dialogs involved in PDA. By direct (as mentioned in this report)
or indirect action, that is, modulation of immune cells,32 we
hypothesize that numerous genes from this stromal signature
can impact on neural remodeling, among other processes.
To realize the present study, we designed in vitro cultures
that mimic the intratumoral compartment. For this purpose, we
usedmesenchymal cells as well as macrophages to represent
the stromal compartment. By cultivating those cells alone or in
combination, we observed that fibroblasts in cocultures with
macrophages shifted their activation status to become
activated as CAFs would be. This suggests that macrophages
have the ability to activate fibroblasts and improve the range of
data showing macrophages as an important mediator of PDA
progression and gemcitabine resistance.33 An in-depth
analysis of the activation mode of those macrophages could
be carried out to determine whether in our model IL-6
secretion is also responsible for macrophage changes and
also to determine the phenotypic changes of these
macrophages together with clinical correlation and patient’s
survival/status.
All data presented here support the fact that the intratumoral
microenvironment, that is, CAFs through the secretion of axon
guidance molecules, impacts on neural remodeling by
increasing nerve density within PDA compared with healthy
pancreas. However, three major questions remain: (i) How do
some tumoral cells have the ability to integrate nerve
structures (between the endoneurium and the perineurium
mainly) to use those contaminated nerve fibers as a route for
locoregional spread and consequent regional invasion or local
recurrence after resection? (ii) How do those new nerve fibers
acquire their pain-related activation status and how can we
block the intercompartment dialog responsible for the pain-
related status as those nerves? (iii) How can we explain that
molecules involved in axon guidance, that is, the SLIT2/ROBO
axis, and, more specifically, in repulsion (within developmental
studies) could have such an important correlation with
intratumoral nerve density?
From a clinical point of view, this report suggests that
blockage of the ‘axon guidance’ family and, more specifically,
the SLIT2/ROBO pathway and its following signaling
(as β-catenin/N-cadherin), may be a therapeutic approach to
reduce PANRaswell as consequent pathophysiologic impacts
on PDA development and patient’s fate (in the form of tumor
recurrence and neuropathic pain). The role of the intratumoral
microenvironment on PANR is a recent concept in PDA
progression, and we look forward to future studies aimed at
addressing the function(s) of other stromal molecules
impacting on PANR as well as the translation of the pathway
described here in other solid cancers associated with neural
remodeling.
Materials and Methods
Human samples. Freshly frozen tissue samples of PDAs (n= 4) were
obtained from patients who had undergone surgery at the Department of Digestive
Surgery. Before surgery, all patients had signed an informed consent form that had
been approved by the local ethics committee (Agreement reference of CRO2 tissue
collection: DC-2013-1857). One of the patients received preoperative chemotherapy
for 2 months. Three patients underwent hemipancreaticoduodenectomy, and one
underwent distal pancreatectomy. No distant metastases were revealed at initial
diagnosis. Histological examination confirmed a diagnosis of PDA in all cases.
Tumor staging was performed according to the International Union Against Cancer
TNM System (the 6th edition).
Mouse strains and tissue collection. Pdx1-cre;Ink4a/Arffl/fl;LSL-KrasG12D
mice were obtained by crossing the following strains: Pdx1-cre, KrasG12D and
Ink4Af/f mice kindly provided by Dr. D Melton (Harvard Stem Cell Institute,
Cambridge, MA, USA), Dr. R Depinho (Dana-Farber Cancer Institute, Boston, MA,
USA) and Dr T Jacks (David H Koch Institute for Integrative Cancer Research,
Cambridge, MA, USA), respectively. Pieces of tumor pancreata were fixed in 4%
(wt/vol) formaldehyde for further immunostaining analysis or prepared for RNA
extraction. All animal care and experimental procedures were performed in
agreement with the Animal Ethics Committee of Marseille.
Xenografts. Patient-derived pancreatic tumor pieces (1 mm3) were embedded
in Matrigel before subcutaneous implantation into the flank of adult male Swiss nude
mice (Charles River Laboratories, Bois des Oncins, France) under isoflurane
anesthesia (induction, 4% (vol/vol); maintenance, 1.5% (vol/vol)). Experimental
procedures were performed using patient-derived pancreatic tumor pieces after
agreement from the South Mediterranean Personal Protection Comity, under the
reference 2011-A01439-32.
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Statistical analysis. Results are presented as average± S.D. All other
comparisons (except Figure 6 and Supplementary Figure 5) were analyzed with the
unpaired, two-sided, independent Student’s t-test without equal variance assump-
tion. Pearson's correlation analysis (SAS Software 9.2) was performed based on the
comparison between Slit2 and αSMA expression, or nerve numbers.
Laser microdissection and microarray analysis. Microdissection was
performed in the microdissection laboratory of the PRIMACEN platform (University
of Rouen, Mont-Saint-Aignan, France) in collaboration with Magalie Bénard. Frozen
sections (20 μm) were obtained from selected tissue samples. After a brief staining
with hematoxylin and eosin, sections were dehydrated. A surface of ~ 2 × 106 and
4 × 106mm2 was microdissected for epithelial and stromal compartments,
respectively, using the PALM system (P.A.L.M. Microlaser Technologies AG,
Bernried, Germany). The microdissected material was immediately dissolved in a
buffer containing β-mercaptoethanol and RNA carrier, and frozen before the RNA
extraction was carried out with the RNAeasy Mini Kit (Qiagen, Courtaboeuf,
France).
RNA extracted from microdissected stromal and tumoral cell samples from each
patient was analyzed separately as follows: 15 μg of total RNA was converted to
cDNA using SuperScript Reverse Transcriptase (Invitrogen, Cergy Pontoise, France),
and T7-oligo-d(T)24 (Genset, Paris, France) was used as a primer. Second-strand
synthesis was performed using T4 DNA polymerase and Escherichia coli DNA ligase
and then blunt ended by T4 polynucleotide kinase. cDNA was purified by phenol–
chloroform extraction using phase lock gels (Brinkmann, Orleáns, France). Then
cDNAs were in vitro transcribed for 16 h at 37 °C using the IVT Labeling Kit
(Affymetrix, Santa Clara, CA, USA) to produce biotinylated cRNA. Labeled cRNAwas
isolated using an RNeasy Mini Kit column (Qiagen). Purified cRNAwas fragmented to
200-30 mer using a fragmentation buffer. The quality of total RNA, cDNA synthesis,
cRNA amplification and cRNA fragmentation was monitored by capillary electro-
phoresis (Bioanalyzer 2100; Agilent Technologies, Massy, France). Fifteen
micrograms of fragmented cRNA was hybridized for 16 h at 45 °C with constant
rotation, using a human oligonucleotide array U133 Plus 2.0 (Genechip; Affymetrix).
After hybridization, chips were processed using the Affymetrix GeneChip Fluidic
Station 450 (protocol EukGE-WS2v5_450). Staining was carried out with streptavidin-
conjugated phycoerythrin (SAPE; Molecular Probes, Eugene, OR, USA), followed by
amplification with a biotinylated anti-streptavidin antibody (Vector Laboratories,
Burlingame, CA, USA), and by a second round of SAPE. Chips were scanned using a
GeneChip Scanner 3000 G7 (Affymetrix) enabled for high-resolution scanning.
Images were extracted with GeneChip Operating Software (Affymetrix GCOS v.1.4).
Quality control of microarray chips was performed using AffyQCReport
software (Affymetrix).34
Background subtraction and normalization of probe set intensities was performed
using the robust multiarray averaging (RMA) described by Irizarry et al.35 To identify
differentially expressed genes between stromal and tumoral compartments in each
tumor, gene expression intensity was compared using a moderated t-test and a Bayes
smoothing approach developed for a low number of replicates.36 To correct for the
effect of multiple testing, the false discovery rate (FDR) was estimated from P-values
derived from the moderated t-test statistics.37 Analysis was performed using the
affylmGUI Graphical User Interface for the limma microarray package38 and with
Partek Genomics Suite (Partek Inc., St. Louis, MO, USA). We scored genes as
differentially expressed if the fold change was41.5 and P-valueo0.05. Raw data
were submitted to the GEO repository under the record number GSE50570.
M&M bioinfo. Individual Affymetrix files were parsed and normalized with
GCRMA using Affy and GCRMA packages with Bioconductor 3.0 (http://www.
bioconductor.org/packages/release/bioc/html/chipseq.html). Differential analysis was
performed with the SAM method (MeV, version 4.8.1) after application of a variance
(top 20% of transcripts were kept). FDR was fixed to 6%, and 1001 genes were
identified as differentially expressed in the stromal tissue compared with tumor
tissue. Gene ontology (GO) enrichment was measured by a hypergeometric
distribution and Bonferroni-corrected.
Heat map highlighting transcripts marked as ‘Axon Guidance’ found to be
significantly overexpressed in stromal tissues than in tumor tissues were generated
with Gene-E from the Broad Institute (Cambridge, MA, USA). Represented values are
normalized GCRMA expression values of individual genes. Each column is related to
a single Affymetrix chip hybridized using the cRNA synthesized from individual
stromal or tumor tissue. Red color represents higher gene expression values and blue
represents lower expression.
Cell isolation and primary CAF culture. Small pancreatic tissue blocks
were obtained from the pancreas during surgery in patients with resectable
pancreatic adenocarcinoma (see Xenograft methods section). The tumors were cut
into small pieces of 1 mm3 using a razor blade. The tissue pieces were digested by
collagenase IV (Sigma-Aldrich, Chesnes, France; C1889) for 30 min at 37 °C,
washed with media, resuspended, passed through a cell strainer (100 μM) and
finally plated in a T75cm2 flask. Tissue blocks trapped in the cell strainer were
seeded into 10 cm2 culture dishes to isolate more PSCs by the outgrowth method.
Cells were cultured in DMEM/F12 medium (Invitrogen; 31330-038), 10% serum
(Sigma-Aldrich; F7524), 2 mmol/l L-glutamine (Invitrogen; 25030-024), 1% antibiotic/
antimycotic (Invitrogen; 15240-062) and 0.5% sodium pyruvate (Invitrogen; 11360-
039) and used for passage 4–8. Primary CAF features were verified by IF for a
positive αSMA staining and a negative CK19 staining.
In vitro modeling of intratumoral microenvironment cell interac-
tions. Panc1 and MiaPaca 2 human cell lines and the mouse pancreatic tumoral
cell line PK4A were used for the epithelial compartment. Human primary fibroblasts
or human CAFs, as well as murine macrophages (RAW 264.7), were used for the
stromal compartment, and human Schwann cells (sNF 96.2) were used for the
nerve cell compartment. All cell lines were obtained from the American Type Culture
Collection (Manassas, VA, USA), except PK4A, human fibroblasts and CAFs, which
are derived from primary cells lines obtained in our laboratory (see Materials and
Methods). Cell lines were cultured in DMEM supplemented with 10% fetal bovine
serum (Sigma-Aldrich; F7524) and 1% of antibiotic/antimycotic (Invitrogen; 15240-
062). The combination of human and murine cell lines was important in our model
as it permits to determine through QPCR analysis, by designing specific human or
mouse primers, which gene expressions are modified in each cell type even when
those cell types are cocultured.
For modeling of intratumoral microenvironment cell interactions, fibroblasts and
macrophage were cultured (cell concentration is dependent on dishes size) in dishes
coated with collagen 0.1% (Sigma-Aldrich) alone or together (1 : 1) for 24 h and then
serum deprived for 12 h. Panc1, MiaPaca 2 and sNF were cultured in uncoated
dishes for 24 h and then serum deprived for 12 h. Conditioned media (Md) from these
cultures were used: Md F (fibroblasts alone); Md M (macrophages alone); Md FcoM
(fibroblasts cocultured with macrophages); Md F+M (Md from fibroblasts alone mixed
to Md from macrophages alone; 1 : 1); Md SNF (sNF 96.2 alone).
Behaviors of primary sensory neurons. Pregnant rats at 15 days'
gestation were killed by cervical dislocation (Wistar rats; Janvier, Le Genest,
France) and the fetuses were removed from the uterus. DRG were collected, placed
in ice-cold Leibovitz medium (L15; Invitrogen) and dissociated by trypsinization
(trypsin, 0.05%; Invitrogen) for 20 min at 37 °C. The reaction was stopped by
the addition of DMEM containing 10% of fetal bovine serum in the presence of
DNAase I (Roche, Meylan, France). The suspension was triturated with a 10 ml
pipette and the cells were mechanically dissociated by several passages through
the 21-gauge needle of a syringe. Cells were then centrifuged at 350 × g for 10 min
at room temperature. The pellet of dissociated cells was resuspended in DMEM-
Ham F12 (Invitrogen) containing 1% N2 (invitrogen), 1% penicillin–streptomycin
(Invitrogen), 1% L-glutamine and 3 ng/ml NGF (PeproTech, Neuilly sur Seyne,
France and Tebu, Perray, France). Cells were seeded on the basis of 15000 cells
per well in a 96-well plate precoated with poly-L-lysine (Sigma-Aldrich). Plates were
maintained at 37 °C in a humidified incubator with 95% air/5% CO2. Cells were
cultured in classic culture medium or in a defined culture medium. On day 5, cells
were fixed in a solution of 4% paraformaldehyde in PBS for 30 min at pH 7.4. After
permeabilization with 0.01% saponin, cells were blocked for 2 h with PBS containing
10% goat serum and then incubated with primary β-tubulin antibody
(Sigma-Aldrich). Revelation was carried out using Alexa Fluor 488 goat anti-
mouse IgG (Molecular Probes). The nuclei of neurons were labeled by a fluorescent
marker (Hoechst solution; Sigma-Aldrich). For each condition, 2 × 10 pictures per
well were taken using AnalyzerTM 1000 (GE Healthcare, Aulnay, France) with x20
magnification. All images were taken under the same conditions and analyzed with
Developer Software (GE Healthcare).
Cell migration assay. Schwann cell migration was studied using the sNF96.2
cell line under various conditioned media on Boyden chambers. Culture inserts
(BD, Le pont le Claix, France) with a porous membrane at the bottom (8 μ pores)
were coated with a mix made of gelatin 0.1% and fibronectin 10 μg/ml, and then
were seeded with sNF96.2 (100 000 per insert) and placed into wells containing the
conditioned media. Migration was performed for 4 h. After cleaning and briefly
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staining inserts with coomassie blue, migration was assessed by counting the
number of colored cells in 10 high-power fields (magnification x20).
QRT-PCR. RNA was extracted from cell lines using TRIzol (Invitrogen) according to
the manufacturer’s instructions. RNA was extracted from the pancreas of 8-week-old
healthy mice (KrasG12D/Ink4Af/f) and PDA-earing mice (pdx1-cre/KrasG12D/Ink4Af/f)
according to Chirgwin’s procedure,39 and RNA quality control was determined using
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). cDNA was
made from 1 μg of total RNA using the ImProm-II Reverse Transcription System
(Promega, Charbonnières, France) according to the manufacturer’s instructions.
QRT-PCR was performed using cDNA amplicons amplified with specific primers and
the GoTaq qPCR Master Mix Kit (Promega) using a Mx3000P Stratagene system
(Agilent Technologies). Relative expression was calculated as a ratio of the
particular gene expression to a housekeeping gene expression (TBP).
Immunofluorescence. Slides from frozen tissue samples or cultured cells
were available for IF. Staining was performed using the following antibodies:
αSMA mouse monoclonal (1 : 2, M-0851 (Dako, Les Ulis, France) or 1 : 200,
A2547 (Sigma-Aldrich)), SLIT2 rabbit polyclonal (1 : 40, sc-28945; Santa Cruz
Biotechnology, Heidelberg, Germany) and cytokeratin 19 mouse monoclonal (1 : 50,
M-0888, Dako). Image quantification was carried out using Image J software (http://
imagej.nih.gov/ij/).
Immunohistochemistry. Slides from frozen human samples or formalin-fixed
mouse samples were available for IHC. Staining was performed using the following
antibodies: SLIT2 rabbit polyclonal (1 : 40, sc-28945; Santa Cruz Biotechnology),
PGP9.5 rabbit polyclonal (1 : 800, ab-10404; Abcam, Cambridge, UK) and AML
mouse monoclonal (1 : 200, A2547; Sigma-Aldrich).
Reagents. For competition studies, blocking SLIT2 antibody (rabbit polyclonal,
1 μg) and associated blocking peptide were obtained from Santa Cruz
Biotechnology (sc-26601 and sc-26601P). Human recombinant SLIT2 (25 pg or
25 ng) was obtained from Abcam (ab82131). Each was added to conditioned
medium during cell migration assays.
siRNA transfection and reporter assay. Human fibroblasts were
transiently transfected using SLIT2 siRNA (EHU068081; Sigma-Aldrich) or control
siRNA (SIC001; Sigma-Aldrich) and ribocellin (BioCellChallenge, Toulon, France)
according to the manufacturer’s instructions. sNF96.2 cells were transiently
transfected using ROBO1, ROBO2 or control siRNA (Origene, Rockville, MD, USA)
and ribocellin (BioCellChallenge) according to the manufacturer’s instructions.
Conditioned media produced from cells were serum-deprived, and then collected for
migration assays, immunoprecipitation or cytoplasmic/nuclear protein extraction.
TCF/LEF reporter assay was performed according to the manufacturer’s instructions
(CCS-018L; SABiosciences, Courtaboeuf, France).
Immunoprecipitation. sNF96.2 cells were incubated with conditioned
media± siRNA for 30 min. Cell layers were washed in cold PBS and incubated
for 10 min in lysis buffer. Cell lysates were cleared by centrifugation at 15000 × g for
15 min. Supernatants were incubated with N-cadherin antibody (rabbit polyclonal,
1 μg, ab18203; Abcam) for 2 h at 4 °C before the addition of agarose beads. After
45 min of incubation with beads at 4 °C, the material was washed three times with
lysis buffer. The immunoprecipitated and input material was eluted in the loading
buffer, fractioned by SDS-PAGE, transferred to nitrocellulose membrane and
immunoblotted with appropriate antibodies: N-cadherin (1 : 250, rabbit polyclonal,
ab18203; Abcam) and β-catenin (1 : 2000, mouse monoclonal, 610153; BD
Transduction Laboratories, Le Pont le Claix, France).
Cytoplasmic and nuclear protein extraction. sNF96.2 cell were
incubated with various conditioned media for 90 min. All steps were performed
with the Nuclear Extract Kit (Active Motif, Carlsbad, CA, USA) according to the
manufacturer’s instructions. Nuclear extracts were resuspended in loading
buffer, fractioned by SDS-PAGE, transferred to nitrocellulose membrane and
immunoblotted with the appropriate antibody: β-catenin (mouse monoclonal,
BD Transduction Laboratories, 1 : 2000) and Lamin A/C (rabbit polyclonal,
Imgenex, 1/1000).
Western blotting. For detection of SLIT2, total proteins were isolated from
human PDA and healthy pancreas. Protein concentrations of the lysates were
determined using the Bradford Protein Assay Reagent (Bio-Rad). Electrophoresis
was carried out using XCell SureLock Mini-Cell (Invitrogen). The extracts (50 μg/
lane) were resolved by 3–7% NuPAGE Novex Tris-Acetate Mini Gels electrophoresis
and electrotransferred onto an Immobilon polyvinylidene difluoride (PVDF)
membrane (Immobilon-PSQ) using an electrophoretic transfer system (Invitrogen).
PVDF membranes were divided into two parts according to the location of molecular
weight markers to permit detection of both C-terminal protein Slit2 (about 55–
60 kDa) and β-tubulin (49 kDa) by western blotting. The latter was used as an
internal control. The membrane was blocked in freshly prepared PBS 1 ×
supplemented with 5% goat serum and 0.5% nonfat dry milk for 1 h at 37 °C. The
membrane was then incubated overnight at 4 °C in a blocking buffer containing Slit2
(rabbit polyclonal antibody, 1 : 100; Santa Cruz Biotechnology) or β-tubulin antibody
(mouse monoclonal antibody, 1 : 5000; Sigma-Aldrich), followed by three washes in
TBST. Thereafter, the membrane was incubated with horseradish peroxidase-
conjugated secondary antibody in TBS 1 × supplemented with 3% BSA (1 : 5000
dilution, goat anti-rabbit or goat anti-mouse IgG-HRP; Santa Cruz Biotechnology) for
1 h at 37 °C. The membranes were developed with an enhanced chemilumines-
cence substrate (Millipore, Fontenay sous Bois, France) and digitally scanned with
Fusion Fx7 (Vilber Lourmat, Collegien, France).
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